Abstract

The objectives of this contract are to produce and/or package experimental vaccines for influenza A viruses, influenza V viruses, paramyxoviruses, rotaviruses, and hepatitis viruses. The viral suspensions produced should be tested and found safe for administration to humans.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI035154-001
Application #
3725869
Study Section
Project Start
1992-11-30
Project End
1998-11-30
Budget Start
1993-09-27
Budget End
1994-06-22
Support Year
Fiscal Year
1993
Total Cost
Indirect Cost

  Institution

Name
Program Resources, Inc.
Department
Type
DUNS #
City
Reston
State
VA
Country
United States
Zip Code

  Publications

Pugh, J C; Guo, J T; Aldrich, C et al. (1998) Aberrant expression of a cytokeratin in a subset of hepatocytes during chronic WHV infection. Virology 249:68-79
Robinson, R A; Burgess, W H; Emerson, S U et al. (1998) Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells. Protein Expr Purif 12:75-84